Abstract
Drugs are the moieties used in treating diseases. Drugs include vaccines, antidepressants, antibiotics, antiviral, anesthetics, stimulants, and inhibitors. Drugs perform functions in the living system and are associated with the change in body metabolism. Various mechanisms are linked to drug distribution and drug action. Mechanisms are specific and they target specific region or process in the body. Mechanisms for antibiotic resistance include modification of bacterial proteins which are the targets of antibiotics, enzymatic modification of antibiotics, reduction in drug uptake, efflux pump modification, plasmid modification, and inhibition of metabolic pathways. Drugs are used individually or in combinations to maximize each other’s effect and minimize the risk. Factors defining drugs efficiency include nature of disease, medical history, drug dosage, treatment time, age, and environmental factors. Drug resistance is the ineffectiveness of drug against a disease after specific period. Factors associated with drug resistance are the excessive or inappropriate use of drugs and the modification in target sites including genetic mutations. Genetic mutations lead to therapeutic and economic problems as new therapies and drug combinations require time and resources. Some pathogens are resistant to multiple drugs known as multi-drug resistance. Drugs designing by considering these challenges can minimize the drug resistance.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Abdul Kadir, L., Stacey, M., & Barrett-Jolley, R. (2018). Emerging roles of the membrane potential: Action beyond the action potential. Frontiers in Physiology, 9, 1661.
Adesoye, A., & Duncan, N. (2017). Acute pain management in patients with opioid tolerance. US Pharm, 42, 28–32.
Adler, L. A., Goodman, D. W., Kollins, S. H., Weisler, R. H., Krishnan, S., Zhang, Y., & Biederman, J. (2008). Double-blind, placebo-controlled study of the efficacy and safety of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder. Journal of Clinical Psychiatry, 69, 1364.
Aira, M., Hartikainen, S., & Sulkava, R. (2005). Community prevalence of alcohol use and concomitant use of medication—a source of possible risk in the elderly aged 75 and older? International Journal of Geriatric Psychiatry: A Journal of the Psychiatry of Late Life and Allied Sciences, 20, 680–685.
Akbari, P., & Khorasani-Zadeh, A. (2019). Thiazide diuretics. StatPearls [Internet]. StatPearls Publishing.
Alberts, B., Johnson, A., Lewis, J., Raff, M., Roberts, K., & Walter, P. (2002). Signaling through G-protein-linked cell-surface receptors. Molecular Biology of the Cell. 4th edition. Garland Science.
Aldred, K. J., Kerns, R. J., & Osheroff, N. (2014). Mechanism of quinolone action and resistance. Biochemistry, 53, 1565–1574.
Alomar, M. J. (2014). Factors affecting the development of adverse drug reactions. Saudi Pharmaceutical Journal, 22, 83–94.
Aslam, B., Wang, W., Arshad, M. I., Khurshid, M., Muzammil, S., Rasool, M. H., Nisar, M. A., Alvi, R. F., Aslam, M. A., & Qamar, M. U. (2018). Antibiotic resistance: A rundown of a global crisis. Infection and Drug Resistance, 11, 1645.
Bauman, R. W. (2015). Microbiology: With diseases by body system (4th ed.). . Pearson Education Inc.
Baxter, K., & Preston, C. L. (2010). Stockley's drug interactions. Pharmaceutical Press London.
Belle, D. J., & Singh, H. (2008). Genetic factors in drug metabolism. American Family Physician, 77, 1553–1560.
Berg, J. M., Tymoczko, J. L., & Stryer, L. (2012). Biochemistry/Jeremy M. Berg, John L. Tymoczko, Lubert Stryer; with Gregory J. Gatto, Jr. WH Freeman.
Besant, P. G., Tan, E., & Attwood, P. V. (2003). Mammalian protein histidine kinases. The International Journal of Biochemistry & Cell Biology, 35, 297–309.
Biaggioni, I., & Robertson, D. (2009). Adrenoceptor agonists & sympathomimetic drugs. Basic & Clinical Pharmacology, 12, 129–149.
Bowman, W. (2006). Neuromuscular block. British Journal of Pharmacology, 147, S277–S286.
Brass, L. F. (2003). Thrombin and platelet activation. Chest, 124, 18S-25S.
Buchner, E. “ Biocatalyst” redirects here. For the use of natural catalysts in organic chemistry, see Biocatalysis.
Caliandro, P., Evoli, A., Stålberg, E., Granata, G., Tonali, P., & Padua, L. (2009). The difficulty in confirming clinical diagnosis of myasthenia gravis in a seronegative patient: A possible neurophysiological approach. Neuromuscular Disorders, 19, 825–827.
Carrière, V., Berthou, F., Baird, S., Belloc, C., & Beaune, P. (1996). Human cytochrome P450 2E1 (CYP2E1): From genotype to phenotype. Pharmacogenetics, 6, 203–211.
Carvalho, M., Carmo, H., Costa, V. M., Capela, J. P., Pontes, H., Remião, F., Carvalho, F., & de Lourdes, B. M. (2012). Toxicity of amphetamines: An update. Archives of Toxicology, 86, 1167–1231.
Charles, L., Triscott, J., & Dobbs, B. (2017). Secondary hypertension: Discovering the underlying cause. American Family Physician, 96, 453–461.
Chiara, D. C., Jayakar, S. S., Zhou, X., Zhang, X., Savechenkov, P. Y., Bruzik, K. S., Miller, K. W., & Cohen, J. B. (2013). Specificity of intersubunit general anesthetic-binding sites in the transmembrane domain of the human α1β3γ2 γ-aminobutyric acid type A (GABAA) receptor. Journal of Biological Chemistry, 288, 19343–19357.
Chillistone, S., & Hardman, J. G. (2017). Factors affecting drug absorption and distribution. Anaesthesia & Intensive Care Medicine, 18, 335–339.
Chopra, I., & Roberts, M. (2001). Tetracycline antibiotics: Mode of action, applications, molecular biology, and epidemiology of bacterial resistance. Microbiology and Molecular Biology Reviews, 65, 232–260.
Chou, T. C., Bjorkum, A. A., Gaus, S. E., Lu, J., Scammell, T. E., & Saper, C. B. (2002). Afferents to the ventrolateral preoptic nucleus. Journal of Neuroscience, 22, 977–990.
CHUNG, K.-T. . (2016). Azo dyes and human health: A review. Journal of Environmental Science and Health, Part C, 34, 233–261.
Colovic, M. B., Krstic, D. Z., Lazarevic-Pasti, T. D., Bondzic, A. M., & Vasic, V. M. (2013). Acetylcholinesterase inhibitors: Pharmacology and toxicology. Current Neuropharmacology, 11, 315–335.
Conney, A., & Bubns, J. (1962). Factors influencing drug metabolism. In Advances in pharmacology. Elsevier.
Corrao, G., Rubbiati, L., Bagnardi, V., Zambon, A., & Poikolainen, K. (2000). Alcohol and coronary heart disease: A meta-analysis. Addiction, 95, 1505–1523.
Currie, G. M. (2018). Pharmacology, part 1: Introduction to pharmacology and pharmacodynamics. Journal of Nuclear Medicine Technology, 46, 81–86.
Daniels, R., & Nicoll, L. H. (2011). Contemporary medical-surgical nursing. Cengage Learning.
de Lencastre, H., Oliveira, D., & Tomasz, A. (2007). Antibiotic resistant Staphylococcus aureus: A paradigm of adaptive power. Current Opinion in Microbiology, 10, 428–435.
Demirkiran, A., Sewgobind, V. D., van der Weijde, J., Kok, A., Baan, C. C., Kwekkeboom, J., Tilanus, H. W., Metselaar, H. J., & van der Laan, L. J. (2009). Conversion from calcineurin inhibitor to mycophenolate mofetil-based immunosuppression changes the frequency and phenotype of CD4+ FOXP3+ regulatory T cells. Transplantation, 87, 1062–1068.
Devadasu, V. R., Deb, P. K., Maheshwari, R., Sharma, P., & Tekade, R. K. (2018). Physicochemical, pharmaceutical, and biological considerations in GIT absorption of drugs. Elsevier.
Dhanasekaran, N., & Reddy, E. P. (1998). Signaling by dual specificity kinases. Oncogene, 17, 1447–1455.
Dworkin, R. H., Backonja, M., Rowbotham, M. C., Allen, R. R., Argoff, C. R., Bennett, G. J., Bushnell, M. C., Farrar, J. T., Galer, B. S., & Haythornthwaite, J. A. (2003). Neurological reviews-advances in neuropathic pain: Diagnosis, mechanisms, and treatment recommendations. Archives of Neurology, 60, 1524–1536.
Elson, D. (1965). Metabolism of nucleic acids (macromolecular DNA and RNA). Annual Review of Biochemistry, 34, 449–486.
Farooqui, R., Hoor, T., Karim, N., & Muneer, M. (2018). Potential drug-drug interactions among patients prescriptions collected from medicine out-patient setting. Pakistan Journal of Medical Sciences, 34, 144.
Finkel, R., Clark, M. A., & Cubeddu, L. X. (2009). Pharmacology: Lippincott’s illustrated reviews. Lippincott Williams & Wilkins.
Garza, A. Z., Park, S. B., & Kocz, R. (2019). Drug elimination. StatPearls [Internet]. StatPearls Publishing.
Gether, U. (2000). Uncovering molecular mechanisms involved in activation of G protein-coupled receptors. Endocrine Reviews, 21, 90–113.
Giluman, A. G. (1987). G proteins: Transducers of receptor-generated signals. Annual Review of Biochemistry, 56, 615–649.
Goldberg, R. M., Mabee, J., Chan, L., & Wong, S. (1996). Drug-drug and drug-disease interactions in the ED: Analysis of a high-risk population. The American Journal of Emergency Medicine, 14, 447–450.
Goldblatt, D. (2000). Conjugate vaccines. Clinical & Experimental Immunology, 119, 1–3.
Gudin, J. (2012). Risk Evaluation and Mitigation Strategies (REMS) for extended-release and long-acting opioid analgesics: Considerations for palliative care practice. Journal of Pain & Palliative Care Pharmacotherapy, 26, 136–143.
Hanukoglu, I. (2017). ASIC and ENaC type sodium channels: Conformational states and the structures of the ion selectivity filters. The FEBS Journal, 284, 525–545.
Harper, S., & Jones, N. (2006). Cocaine: What role does it have in current ENT practice? A review of the current literature. The Journal of Laryngology & Otology, 120, 808–811.
Haverkampf, J. (2017). Benzodiazepines Z-drugs and dependence.
Henry, R. J. (1943). The mode of action of sulfonamides. Bacteriological Reviews, 7, 175.
Herman, L. L., & Bashir, K. (2019). Angiotensin converting enzyme inhibitors (ACEI). StatPearls [Internet]. StatPearls Publishing.
Hermanson, G. T. (2013). Bioconjugate techniques. Academic press.
Hippius, H. (1989). The history of clozapine. Psychopharmacology.
Housman, G., Byler, S., Heerboth, S., Lapinska, K., Longacre, M., Snyder, N., & Sarkar, S. (2014). Drug resistance in cancer: An overview. Cancers, 6, 1769–1792.
Jenkins, C., Samudrala, R., Anderson, I., Hedlund, B. P., Petroni, G., Michailova, N., Pinel, N., Overbeek, R., Rosati, G., & Staley, J. T. (2002). Genes for the cytoskeletal protein tubulin in the bacterial genus Prosthecobacter. Proceedings of the National Academy of Sciences, 99, 17049–17054.
Johns, M. (1975). Sleep and hypnotic drugs. Drugs, 9, 448–478.
Kalivas, P. W., & McFarland, K. (2003). Brain circuitry and the reinstatement of cocaine-seeking behavior. Psychopharmacology (berl), 168, 44–56.
Kang, H.-K., & Park, Y. (2015). Glycopeptide antibiotics: Structure and mechanisms of action. Journal of Bacteriology and Virology, 45, 67–78.
Kapalka, G. M. (2009). Nutritional and herbal therapies for children and adolescents: A handbook for mental health clinicians. Academic Press.
Karch, S. (2009). Karch’s pathology of drug abuse (pp. 635–648). Taylor & Francis Group.
Kelley, A. G., Ling-Hsiu, L., & Berenbaum, M. (2017). You are what you eat: Food-drug interaction in honey bees (Apis mellifera).
Khalil, H., & Zeltser, R. (2020). Antihypertensive medications. StatPearls [Internet]. StatPearls Publishing.
King, J. V., Liang, W. G., Scherpelz, K. P., Schilling, A. B., Meredith, S. C., & Tang, W.-J. (2014). Molecular basis of substrate recognition and degradation by human presequence protease. Structure, 22, 996–1007.
Klee, H. (1997). Amphetamine misuse: International perspectives on current trends. CRC Press.
Kleiner, D. E. (2018). Drugs and toxins. Elsevier.
Kojetin, D. J., & Burris, T. P. (2014). REV-ERB and ROR nuclear receptors as drug targets. Nature Reviews Drug Discovery, 13, 197–216.
Koppes, L. L., Dekker, J. M., Hendriks, H. F., Bouter, L. M., & Heine, R. J. (2005). Moderate alcohol consumption lowers the risk of type 2 diabetes: a meta-analysis of prospective observational studies. Diabetes Care, 28, 719–725.
Kosztin, D., Izrailev, S., & Schulten, K. (1999). Unbinding of retinoic acid from its receptor studied by steered molecular dynamics. Biophysical Journal, 76, 188–197.
Krause, K. M., Serio, A. W., Kane, T. R., & Connolly, L. E. (2016). Aminoglycosides: An overview. Cold Spring Harbor Perspectives in Medicine, 6, a027029.
Kronenberger, T., Keminer, O., Wrenger, C., & Windshügel, B. (2015). Nuclear receptor modulators—current approaches and future perspectives. Drug Discovery and Development–From Molecules to Medicine. InTech.
Lally, J., & Maccabe, J. H. (2015). Antipsychotic medication in schizophrenia: A review. British Medical Bulletin, 114, 169–179.
Lambert, D. (2004). Drugs and receptors. Continuing Education in Anaesthesia Critical Care & Pain, 4, 181–184.
Lambert, P. A. (2005). Bacterial resistance to antibiotics: Modified target sites. Advanced Drug Delivery Reviews, 57, 1471–1485.
Li, B., & Sperling, A. (2013). Drug resistance. In Encyclopedia of genetics (pp. 418–420).
Liberti, S., Sacco, F., Calderone, A., Perfetto, L., Iannuccelli, M., Panni, S., Santonico, E., Palma, A., Nardozza, A. P., & Castagnoli, L. (2013). HuPho: The human phosphatase portal. The FEBS Journal, 280, 379–387.
Lin, L., & Wong, H. (2017). Predicting oral drug absorption: mini review on physiologically-based pharmacokinetic models. Pharmaceutics, 9, 41.
Lobanovska, M., & Pilla, G. (2017). Focus: Drug development: Penicillin’s discovery and antibiotic resistance: Lessons for the future? The Yale Journal of Biology and Medicine, 90, 135.
Loeffler, J., & Stevens, D. A. (2003). Antifungal drug resistance. Clinical Infectious Diseases, 36, S31–S41.
Loke, M. F., & Hanafi, A. (2019). Molecular mechanisms responsible for drug resistance.
Löscher, W., & Rogawski, M. A. (2012). How theories evolved concerning the mechanism of action of barbiturates. Epilepsia, 53, 12–25.
Louis, S. (2011). Goodman & Gilman's pharmacological basis of therapeutics.
Ma, W., Yang, L., & He, L. (2018). Overview of the detection methods for equilibrium dissociation constant KD of drug-receptor interaction. Journal of Pharmaceutical Analysis, 8, 147–152.
Madruga, J. V., Berger, D., McMurchie, M., Suter, F., Banhegyi, D., Ruxrungtham, K., Norris, D., Lefebvre, E., de Béthune, M.-P., & Tomaka, F. (2007). Efficacy and safety of darunavir-ritonavir compared with that of lopinavir-ritonavir at 48 weeks in treatment-experienced, HIV-infected patients in TITAN: a randomised controlled phase III trial. The Lancet, 370, 49–58.
Maheshwari, R., Sharma, P., Seth, A., Taneja, N., Tekade, M., & Tekade, R. K. (2018). Drug disposition considerations in pharmaceutical product. Elsevier.
Makley, L. N., & Gestwicki, J. E. (2013). Expanding the number of ‘druggable’ targets: Non-enzymes and protein–protein interactions. Chemical Biology & Drug Design, 81, 22–32.
Manning, G., Whyte, D., Martinez, R., Hunter, T., & Sudarsanam, S. (2002). cAMP-dependent protein kinase from Plasmodium falciparum: An update. Trends in Biochemical Sciences, 27, 514–520.
Marshall, W. F., & Blair, J. E. (1999). The cephalosporins. In Mayo Clinic Proceedings (pp. 187–195). Elsevier.
Mcgowan, J. R., & J. E. (2001). Economic impact of antimicrobial resistance. Emerging Infectious Diseases, 7, 286.
Medicine, N. L. O. (2000). Medical subject headings. US Department of Health and Human Services, Public Health Service, National ….
Munita, J. M., & Arias, C. A. (2016). Mechanisms of antibiotic resistance. In Virulence mechanisms of bacterial pathogens (pp. 481–511).
Murphy, J. M., Farhan, H., & Eyers, P. A. (2017). Bio-Zombie: the rise of pseudoenzymes in biology. Biochemical Society Transactions, 45, 537–544.
Murphy, J. M., Zhang, Q., Young, S. N., Reese, M. L., Bailey, F. P., Eyers, P. A., Ungureanu, D., Hammaren, H., Silvennoinen, O., & Varghese, L. N. (2014). A robust methodology to subclassify pseudokinases based on their nucleotide-binding properties. Biochemical Journal, 457, 323–334.
Nelson, D. L., & Cox, M. M. (2009). Lehninger principles of biochemistry. WH Freeman.
Nieuwstraten, C., Labiris, N. R., & Holbrook, A. (2006). Systematic overview of drug interactions with antidepressant medications. The Canadian Journal of Psychiatry, 51, 300–316.
Nikaido, H. (2003). Molecular basis of bacterial outer membrane permeability revisited. Microbiology and Molecular Biology Reviews, 67, 593–656.
Nikaido, H. (2009). Multidrug resistance in bacteria. Annual Review of Biochemistry, 78, 119–146.
Nuez Veulens, A. D. L., & Rodríguez, R. (2009). G Protein-coupled receptors as targets for drug design. Biotecnología Aplicada, 26, 24–33.
O’Connell, H., Chin, A.-V., Cunningham, C., & Lawlor, B. (2003). Alcohol use disorders in elderly people–redefining an age old problem in old age. BMJ, 327, 664–667.
Oliveira, L., Paiva, A. C. D. M., & Vriend, G. (1993). A common motif in G-protein-coupled seven transmembrane helix receptors. Journal of Computer-Aided Molecular Design, 7, 649–658.
Olkkola, K. T., & Ahonen, J. (2008). Midazolam and other benzodiazepines. Springer.
Opioids, A.-D. (2015). Evaluation and labeling guidance for industry. US Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER) Clinical Medical.
Ozawa, Y., Hayashi, K., & Kobori, H. (2006). New generation calcium channel blockers in hypertensive treatment. Current Hypertension Reviews, 2, 103–111.
Pacheco, M. A. (2007). Receptor types and subtypes.
Page, C. P. (2002). Integrated pharmacology.
Pagès, J.-M., James, C. E., & Winterhalter, M. (2008). The porin and the permeating antibiotic: a selective diffusion barrier in Gram-negative bacteria. Nature Reviews Microbiology, 6, 893–903.
Palomino, J. C., & Martin, A. (2014). Drug resistance mechanisms in mycobacterium tuberculosis. Antibiotics, 3, 317–340.
Panula, P., Chazot, P., Cowart, M., Gutzmer, R., Leurs, R., Liu, W., Stark, H., Thurmond, R., & Haas, H. (2014). International Union of Basic and< tep-common: author-query> AQ9: Please check whether the updated information in ref 1 is correct.</tepcommon: author-query> Clinical Pharmacology XCVIII. Histamine Receptors. Pharmacological Reviews, 67, 601–655.
Pelet, T., & Matheux, F. (2011). Methods for inhibiting gram-postive bacteria using non-phospholipid lipid vesicules. Google Patents.
Pomara, C., Cassano, T., D’Errico, S., Bello, S., Romano, A. D., Riezzo, I., & Serviddio, G. (2012). Data available on the extent of cocaine use and dependence: Biochemistry, pharmacologic effects and global burden of disease of cocaine abusers. Current Medicinal Chemistry, 19, 5647–5657.
Poole, K. (2005). Efflux-mediated antimicrobial resistance. Journal of Antimicrobial Chemotherapy, 56, 20–51.
Pulendran, B., & Ahmed, R. (2011). Immunological mechanisms of vaccination. Nature Immunology, 12, 509.
Qi, X., Lin, W., Ma, M., Wang, C., He, Y., He, N., Gao, J., Zhou, H., Xiao, Y., & Wang, Y. (2016). Structural basis of rifampin inactivation by rifampin phosphotransferase. Proceedings of the National Academy of Sciences, 113, 3803–3808.
Rajesh, D. (2015). The need of a uniform drug classification in text books of pharmacology. Indian Journal of Pharmacology, 47.
Ramirez, M. S., & Tolmasky, M. E. (2010). Aminoglycoside modifying enzymes. Drug Resistance Updates, 13, 151–171.
Rappuoli, R., de Gregorio, E., & Costantino, P. (2019). On the mechanisms of conjugate vaccines. Proceedings of the National Academy of Sciences, 116, 14–16.
Rasmussen, N. (2006). Making the first anti-depressant: Amphetamine in American medicine, 1929–1950. Journal of the History of Medicine and Allied Sciences, 61, 288–323.
Renau, T. E., Hecker, S. J., & Lee, V. J. (1998). Antimicrobial potentiation approaches: Targets and. In Annual reports in medicinal chemistry (p. 121).
Reynolds, K., Lewis, B., Nolen, J. D. L., Kinney, G. L., Sathya, B., & He, J. (2003). Alcohol consumption and risk of stroke: A meta-analysis. JAMA, 289, 579–588.
Rich, R. R., Fleisher, T. A., Shearer, W. T., Schroeder JR, H. W., Frew, A. J., & Weyand, C. M. (2012). Clinical immunology E-Book: Principles and practice. Elsevier Health Sciences.
Rimm, E. B., Klatsky, A., Grobbee, D., & Stampfer, M. J. (1996). Review of moderate alcohol consumption and reduced risk of coronary heart disease: is the effect due to beer, wine, or spirits? BMJ, 312, 731–736.
Sanders, B., Koldijk, M., & Schuitemaker, H. (2015). Inactivated viral vaccines. In Vaccine analysis: Strategies, principles, and control. Springer.
Sano, K., Totsuka, Y., Ikegami, Y., & Uesugi, T. (2001). Metabolism of sulphobromophthalein I: Positional isomers of sulphobromophthalein monoglutathione conjugate. Journal of Pharmacy and Pharmacology, 53, 1015–1020.
Sarker, S. D., & Nahar, L. (2007). Chemistry for pharmacy students (pp. 322–324). Willey & Sons Ltd.
Schiller, J., & Lowy, D. (2018). Explanations for the high potency of HPV prophylactic vaccines. Vaccine, 36, 4768–4773.
Schwarz, S., Kehrenberg, C., Doublet, B., & Cloeckaert, A. (2004). Molecular basis of bacterial resistance to chloramphenicol and florfenicol. FEMS Microbiology Reviews, 28, 519–542.
Shen, Y., Joachimiak, A., Rosner, M. R., & Tang, W.-J. (2006). Structures of human insulin-degrading enzyme reveal a new substrate recognition mechanism. Nature, 443, 870–874.
Shorter, E. (2005). A historical dictionary of psychiatry, Oxford University Press.
Sinha, J., & Bhattacharya, S. (2014). A text book of immunology (Google book preview). Academic Publishers.
Smith, A. M., Feldman, C., Massidda, O., McCarthy, K., Ndiweni, D., & Klugman, K. P. (2005). Altered PBP 2A and its role in the development of penicillin, cefotaxime, and ceftriaxone resistance in a clinical isolate of Streptococcus pneumoniae. Antimicrobial Agents and Chemotherapy, 49, 2002–2007.
Smith, H. S., Raffa, R. B., Pergolizzi, J. V., Taylor, R., & Tallarida, R. J. (2014). Combining opioid and adrenergic mechanisms for chronic pain. Postgraduate Medicine, 126, 98–114.
St Leger, A. S., Cochrane, A. L., & Moore, F. (1979). Factors associated with cardiac mortality in developed countries with particular reference to the consumption of wine. The Lancet, 313(8124), 1017–1020.
Stapleton, P. D., & Taylor, P. W. (2002). Methicillin resistance in Staphylococcus aureus: Mechanisms and modulation. Science Progress, 85, 57–72.
Strader, C. D., Fong, T. M., Tota, M. R., Underwood, D., & Dixon, R. A. (1994). Structure and function of G protein-coupled receptors. Annual Review of Biochemistry, 63, 101–132.
Strømgaard, K., Krogsgaard-Larsen, P., & Madsen, U. (2017). Textbook of drug design and discovery. CRC press.
Suvarna, B. (2011). Drug-receptor interactions. Kathmandu University Medical Journal, 9, 203–207.
Swaan, P. W. (2003). Membrane transport proteins and drug transport. Burger’s Medicinal Chemistry and Drug Discovery, 2, 249–293.
Tan, M., & Jiang, X. (2017). Recent advancements in combination subunit vaccine development. Human Vaccines & Immunotherapeutics, 13, 180–185.
Tanwar, J., Das, S., Fatima, Z., & Hameed, S. (2014). Multidrug resistance: An emerging crisis. Interdisciplinary Perspectives on Infectious Diseases.
Tapert, S. F., Tate, S. R., & Brown, S. A. (2002). Substance abuse: An overview. Springer.
Terzi, H. A., Kulah, C., Atasoy, A. R., & Ciftci, I. H. (2015). Investigation of OprD porin protein levels in carbapenem-resistant Pseudomonas aeruginosa isolates. Jundishapur Journal of Microbiology, 8.
Vartak, A., & Sucheck, S. J. (2016). Recent advances in subunit vaccine carriers. Vaccines, 4, 12.
Vaux, B., & Golder, S. (2003). The Harvard dialect survey. Harvard University Linguistics Department.
Vetter, V., Denizer, G., Friedland, L. R., Krishnan, J., & Shapiro, M. (2018). Understanding modern-day vaccines: What you need to know. Annals of Medicine, 50, 110–120.
Victoria, J. G., Wang, C., Jones, M. S., Jaing, C., McLoughlin, K., Gardner, S., & Delwart, E. L. (2010). Viral nucleic acids in live-attenuated vaccines: Detection of minority variants and an adventitious virus. Journal of Virology, 84, 6033–6040.
Voet, D., Voet, J. G. & Pratt, C. W. (2013). Fundamentals of biochemistry: Life at the molecular level.
Washton, A. M., & Zweben, J. E. (2006). Treating alcohol and drug problems in psychotherapy practice: Doing what works. Guilford Press.
Weathermon, R., & Crabb, D. W. (1999). Alcohol and medication interactions. Alcohol Research & Health, 23, 40.
Williams, S. E. (1980). The use of beverage alcohol as medicine, 1790–1860. Journal of Studies on Alcohol, 41, 543–566.
Wilson, D. N. . (2014). Ribosome-targeting antibiotics and mechanisms of bacterial resistance. Nature Reviews Microbiology, 12, 35–48.
Yadav, D. K., Yadav, N., & Khurana, S. M. P. (2014). Vaccines: Present status and applications. Elsevier.
Zhang, X.-X., Zhang, T., & Fang, H. H. (2009). Antibiotic resistance genes in water environment. Applied Microbiology and Biotechnology, 82, 397–414.
Zhu, B. T. (1993). The competitive and noncompetitive antagonism of receptor-mediated drug actions in the presence of spare receptors. Journal of Pharmacological and Toxicological Methods, 29, 85–91.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Ashraf, S. et al. (2021). Introduction to Drugs, Drug Targets and Drug Resistance. In: Ahmed, S., Chandra Ojha, S., Najam-ul-Haq, M., Younus, M., Hashmi, M.Z. (eds) Biochemistry of Drug Resistance. Springer, Cham. https://doi.org/10.1007/978-3-030-76320-6_1
Download citation
DOI: https://doi.org/10.1007/978-3-030-76320-6_1
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-76319-0
Online ISBN: 978-3-030-76320-6
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)